Literature DB >> 34097212

To the editor, response letter.

A J Conde-Moreno1, D Zucca2, M J Pérez-Calatayud3, F López-Campos4, F Celada5, C Rubio2, P Fernández-Letón6,7, A Gómez-Caamaño8, D Guirado9, J Contreras10.   

Abstract

Entities:  

Year:  2021        PMID： 34097212     DOI： 10.1007/s12094-021-02641-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  1 in total

1.  Letter to the editor.

Authors:  K Sallabanda; L Ley
Journal:  Clin Transl Oncol       Date:  2021-06-07       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.